Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries

Author:

Brieger David,Pocock Stuart J.,Blankenberg Stefan,Chen Ji Yan,Cohen Mauricio G.,Granger Christopher B.,Grieve Richard,Nicolau Jose C.,Simon Tabassome,Westermann Dirk,Yasuda Satoshi,Gregson John,Rennie Kirsten L.,Hedman Katarina,Sundell Karolina Andersson,Goodman Shaun G.

Funder

AstraZeneca

Bayer

Boehringer Ingelheim

Bristol Myers Squibb

Eli Lilly and Company

Merck

Novartis

Sanofi

Abbott

Abbott Diagnostics

Medtronic

Pfizer

Roche

Siemens

Siemens Diagnostics

Thermo Fisher Scientific

Abiomed

Merit Medical

Armetheon

Bristol-Myers Squibb

Daiichi Sankyo

Gilead

GlaxoSmithKline

F. Hoffmann-La Roche

Janssen Pharmaceuticals

Metronic

Salix Pharmaceuticals

Takeda Pharmaceutical Company

The Medicines Company.

Amgen

BMS

CLS Behring

Astellas

Amgen Inc.

Berlin-Chemie

Biotronik

Daiichi-Sankyo

CSL Behring

Fenix Group International

Ferring Pharmaceuticals

Johnson & Johnson

Luitpold Pharmaceuticals

Matrizyme

Regeneron

Servier

Tenax Pharmaceuticals

HLS Therapeutics

Novo-Nordisk

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3